News | November 29, 2007

Study Sides with CADStream for Evaluation of Kinetics in Breast MRI

November 30, 2007 – Confirma announced that a study presented at RSNA found that the CADstream system’s patented “worst curve” algorithm for analyzing kinetics may assist in determining malignancy, concluding that any washout enhancement was associated with malignancy in nearly half of lesions.

The study, by the Seattle Cancer Care Alliance and the University of Washington, led by Dr. Lilian Wang, focused on the evaluation of kinetics and found that the most suspicious curve as identified by CADstream was significantly different between benign and malignant lesions. These findings support the recommendation of the American College of Radiology’s Breast Imaging Reporting and Database System (BI-RADS) Atlas for breast MRI to report the “worst looking” curve.

Entitled MRI Detected Suspicious Breast Findings: Comparison of Kinetic Features Measured by Computer-aided Evaluation in Benign and Malignant Lesion, the study examined 125 suspicious lesions (42 malignant, 83 benign) for which computer-aided-evaluation (CADstream) and subsequent image guided biopsy had been performed, out of a pool of 1538 breast MRI examinations conducted from November 2004 to November 2006.

The study compared three distinct computer-aided-evaluation kinetic features of suspicious breast MRI lesions to identify which may best predict benign or malignant outcomes, concluding that of the kinetic features analyzed only the most suspicious curve type as identified by CADstream was significantly different between benign and malignant lesions.

The CADstream system automates analysis, reporting and interventional planning of studies and promotes standardization with the incorporation of the American College of Radiology’s Breast Imaging Reporting and Database System (BI-RADS), which guides the breast cancer diagnostic routine and decision-making process. Confirma’s next-generation version of CADstream for breast MRI, launched this week at the RSNA meeting, includes a new customizable BI-RADS-centric user interface that accommodates a variety of user experience levels. Other CADstream enhancements include improved 3D renderings and tools for morphology reporting.

For more information: www.confirma.com

Related Content

Transpara Deep Learning Software Matches Experienced Radiologists in Mammogram Reading
News | Computer-Aided Detection Software | January 12, 2018
Deep learning and artificial intelligence improves the efficiency and accuracy of reading mammograms, according to...
Videos | Artificial Intelligence | December 19, 2017
A post-game roundup by ITN Contributing Editor Greg Freiherr and ITN Editor Dave Fornell on the key trend of artifici
iCAD's PowerLook Tomo Detection Experiences Growing Adoption
News | Mammography | December 14, 2017
December 14, 2017 — iCAD Inc.
Infervision Launches AI Platform to Help Radiologists Diagnose Stroke Faster
Technology | Computed Tomography (CT) | November 28, 2017
Infervision is introducing what it calls the first and only artificial intelligence (AI) platform to help radiologists...
Kansas City Radiology Center Employs iCAD PowerLook Tomo Detection for DBT
News | Computer-Aided Detection Software | November 10, 2017
November 10, 2017 — Imaging for Women, a leading radiology center in Kansas City, Mo., announced it is now using iCAD
Zebra Medical Vision Collaborating With Google Cloud on AI-Based Imaging Platform
News | Artificial Intelligence | November 09, 2017
Deep learning imaging analytics company Zebra Medical Vision announced that all its current and future radiology...
CureMetrix Expands Medical Advisory Board
News | Computer-Aided Detection Software | November 08, 2017
November 8, 2017 — CureMetrix, a company developing...
PowerLook Tomo Detection Named 2017 New Hampshire High Technology Council Product of the Year
News | Computer-Aided Detection Software | October 27, 2017
iCAD Inc. announced that its PowerLook Tomo Detection has been named 2017 Product of the Year by the New Hampshire High...
Matrix Analytics Beginning Validation of Deep Learning Lung CT Tools
News | Lung Cancer | September 13, 2017
Matrix Analytics announced it will clinically validate its LungDirect deep learning and predictive analytics tools for...
20/20 GeneSystems Launches AI-Based Lung Cancer Detection Technology in China
Technology | Lung Cancer | August 28, 2017
20/20 GeneSystems Inc. recently released in China what is believed to be the world’s first machine learning algorithm...
Overlay Init